"10.1371_journal.pone.0042771","none","2012-08-27T00:00:00Z","Renaud Lacroix; Andrew R McKemey; Norzahira Raduan; Lim Kwee Wee; Wong Hong Ming; Teoh Guat Ney; Siti Rahidah A.A.; Sawaluddin Salman; Selvi Subramaniam; Oreenaiza Nordin; Norhaida Hanum A.T.; Chandru Angamuthu; Suria Marlina Mansor; Rosemary S Lees; Neil Naish; Sarah Scaife; Pam Gray; Geneviève Labbé; Camilla Beech; Derric Nimmo; Luke Alphey; Seshadri S Vasan; Lee Han Lim; Nazni Wasi A.; Shahnaz Murad","Oxitec Sendirian Berhad, Kuala Lumpur, Wilayah Persekutuan, Malaysia; Oxitec Limited, Oxford, Oxfordshire, United Kingdom; Medical Entomology Unit, Institute for Medical Research, Kuala Lumpur, Wilayah Persekutuan, Malaysia; Centre for Research in Biotechnology for Agriculture, University of Malaya, Kuala Lumpur, Wilayah Persekutuan, Malaysia; Department of Zoology, University of Oxford, Oxford, Oxfordshire, United Kingdom","Conceived and designed the experiments: RL AM. Performed the experiments: RL AM NR LKW WHM TGN SRAA S. Salman S. Subramaniam ON NHAT CA SMM RSL S. Scaife. Analyzed the data: RL. Wrote the paper: RL AM LA CB DN LHL NWA SM. Egg production and development of the strain in the UK: NN PG GL DN. Regulatory: CB LA AM DN SSV LHL NWA SM.","Authors affiliated to Oxitec Ltd. or Oxitec Sdn Bhd are past or present staff or students of Oxitec Ltd. or Oxitec Sdn Bhd. These authors also have, or had, shares or share options in Oxitec Ltd. The genetically modified line of Aedes aegypti OX513A used in the study is a product of Oxitec Ltd. and contains patented technology owned by Oxitec Ltd. and Oxford University. Specific details will be made available upon request. This does not alter the authors adherence to all the PLoS ONE policies on sharing data and materials, as detailed online in the guide for authors. All other authors declare no conflicting interests.","2012","08","Renaud Lacroix","RL",25,TRUE,2,8,1,8,TRUE,TRUE,TRUE,3,"10;11;12",TRUE
